Your browser version may not work well with NCBI's Web applications. More information here...
1: Exp Neurol. 2006 Jun;199(2):446-53. Epub 2006 Feb 17.Click here to read Links
Comment in:
Exp Neurol. 2006 Nov;202(1):1-7.

Lesions in monkey globus pallidus externus exacerbate parkinsonian symptoms.

Center for Neurological Restoration, Cleveland Clinic Foundation, 9500 Euclid Avenue, S31, Cleveland, OH 44195, USA.

To further define the role of the external segment of the globus pallidus (GPe) in the development of parkinsonian motor signs, two rhesus monkeys were made parkinsonian with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Behavioral assessments of bradykinesia and akinesia as well as single neuron recordings in the internal segment of the globus pallidus (GPi) were performed in both monkeys before and after ablating the sensorimotor portion of GPe. The effects of apomorphine on behavior and neuronal activity were also assessed in the parkinsonian monkeys before and after GPe ablation. We found that lesions in GPe exacerbated parkinsonian symptoms, altered neuronal activity in GPi, and reduced the therapeutic effects of apomorphine. These results support the hypothesis that GPe can influence GPi neuronal activity and is directly involved in parkinsonism. In addition, these data suggest that the inclusion of GPe in pallidotomy lesions for the treatment of Parkinson's disease can block the beneficial effects of antiparkinsonian medications and should be avoided.

PMID: 16487515 [PubMed - indexed for MEDLINE]

Patient Drug Information

  • Apomorphine (Apokyn® )

    Apomorphine is used to treat ''off'' episodes (times of difficulty moving, walking, and speaking that may happen as medication wears off or at random) in patients with Parkinson's disease (PD; a disorder of the nervous s...